Scientific Program
Time: July 22-24, 2023
Venue: Catalonia Barcelona Plaza, Spain
|
Registration Time: 09:00-21:00, July 21, 2023 (Friday); Place: Lobby, Ground Floor, Catalonia Barcelona Plaza |
|
|
|
|
|
Opening Ceremony Time: 09:00-09:10, July 22, 2023 (Saturday); Place: Barcelona C, B1, Catalonia Barcelona Plaza |
|
|
|
|
|
Keynote Forum Time: 09:10-12:15, July 22, 2023 (Saturday); Place: Barcelona C, B1, Catalonia Barcelona Plaza |
|
|
|
|
|
Moderator |
Dr. Jana Hawley, Dean & Professor, University of North Texas, USA |
|
|
|
|
09:10-09:15 |
Moderator's Introduction |
|
09:15-09:45 |
Title: Mechanisms underlying Heterogeneous Outcome of Immune Checkpoint Inhibitors in Mouse HNSCC Models Dr. Jing H. Wang, Professor, UPMC Hillman Cancer Center, University of Pittsburgh, USA |
|
09:45-10:15 |
Title: Smart Materials, Underlying Physics, and Specific Magnetic Metals and Oxide Systems Dr. Vincent G. Harris, William Lincoln Smith Chair Professor, Northeastern University, Boston, USA |
|
10:15-10:45 |
Title: Sustainability Framework and Smart Materials Dr. Florian Kongoli, Executive President, FLOGEN Technologies Inc., Canada |
|
10:45-11:15 |
Title: Porous Crystalline Materials - Structure and Functionality |
|
11:15-11:45 |
Title: New Material Technologies are the Enablers to Electric Vertical Take off and Landing Air Taxis |
|
11:45-12:15 |
Title: Prospects for Targeted Protein Degraders in the Fight against Aggressive Cancer |
|
WCC 01: Cancer Cell Biology & Genetics Time: 13:30-17:10, July 22, 2023 (Saturday); Place: Plaza 3, B1, Catalonia Barcelona Plaza |
|
|
|
|
|
Chair |
Dr. Rony Seger, Professor, Weizmann Institute of Science, Israel |
|
Co-Chair |
Dr. Xin Wang, Associate Professor, The Chinese University of Hong Kong, Hong Kong, China |
|
|
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Keynote Speech Title: The Nuclear Translocation of ERK as a Therapeutic Target for Cancer and Inflammation Dr. Rony Seger, Professor, Weizmann Institute of Science, Israel |
|
14:00-14:20 |
Title: Epigenomic Regulation of Tumor Suppression in Acute Lymphoblastic Leukemia Dr. Sinisa Dovat, Professor, Penn State College of Medicine, USA |
|
14:20-14:40 |
Title: The Molecular Signature of Metastasis in the Early Stages of Clear Cell Renal Cell Carcinoma Dr. Xinhua Zhu, Associate Professor, Northwell Health Cancer Institute, USA |
|
14:40-15:00 |
Title: The Ubiquitin-Independent Protein Degradation Pathway in Cancer Progression Dr. Henry James Li, Professor, New York University-Shanghai, China |
|
15:00-15:20 |
Title: Elucidating Osteoclast-Breast Tumor Hybrids Cell Fusion Mechanisms for Bone Metastatic Disease Progression Dr. Kwan T. Chow, Assistant Professor, City University of Hong Kong, Hong Kong, China |
|
15:20-15:30 |
Coffee Break |
|
15:30-15:50 |
Title: Dissecting the Molecular Heterogeneity of Young-onset Colorectal Cancer Dr. Xin Wang, Associate Professor, The Chinese University of Hong Kong, Hong Kong, China |
|
15:50-16:10 |
Title: Intricating Membrane Transport and Metabolism with Intracellular pH Regulation. Insights into Mechanisms, Robustness, And Functional Redundancy Dr. Laurent Counillon, Professor, Université Côte d'Azur, France |
|
16:10-16:30 |
Title: Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis Dr. Da Jung Kim, Director of Metabolomics Core Facility, Seoul National University Hospital, South Korea |
|
16:30-16:50 |
Title: Aberrantly High Allelic Expressions of GNAS, HM13 and SNU13 Imprinted Genes as Novel Biomarkers for Early Cervical Cancer Detection Dr. Xue Xiao, Professor, Sichuan University, China |
|
16:50-17:10 |
Title: The p207 S LysRS–Ap4A–Hint-1–MITF Pathway in Health and Diseases Dr. Ehud Razin, Professor, Hebrew University Hadassah Medical School, Israel |
|
WCC 02: Anti-Cancer Drug Discovery and Development Time: 08:30-11:30, July 23, 2023 (Sunday); Place: Plaza 4, B1, Catalonia Barcelona Plaza |
|
|
|
|
|
Chair |
Dr. Pran K. Datta, Professor, University of Alabama at Birmingham, USA |
|
Co-Chair |
Dr. Lixin Rui, Associate Professor, University of Wisconsin-Madison, USA |
|
|
|
|
08:30-08:35 |
Chair's Introduction |
|
08:35-08:55 |
Title: Ablation rate and Thyroglobulin Decrease after Low-dose 131-I in Differentiated Thyroid Carcinoma Post-Total Thyroidectomy at Vietnam National Cancer Hospital Dr. Duong Duc Binh, Nuclear Medicine Physician, Vietnamese National Cancer Hospital (K hospital), Vietnam |
|
08:55-09:15 |
Title: Anticancer Activity of Selected Plants of Israel and Palestine Dr. Abdullatif Azab, Researcher, Eastern Plants Company, Israel |
|
09:15-09:35 |
Title: ME-503 for Immune-Oncology Treatment: A Novel Mode of Action Dr. Hans Lentzen, Managing Director, MELEMA Pharma GmbH, Germany |
|
09:35-09:55 |
Title: Targeting Ibrutinib Resistance in B Cell Lymphoma Dr. Lixin Rui, Associate Professor, University of Wisconsin-Madison, USA |
|
09:55-10:15 |
Title: Molecular Mechanisms of Colon Tumorigenesis Dr. Pran K. Datta, Professor, University of Alabama at Birmingham, USA |
|
10:15-10:30 |
Coffee Break |
|
10:30-10:50 |
Title: Chemo-Immunotherapy of Nanomedicine and anti-PD-1 Antibody for Reprogramming Tumor Microenvironment to Overcome anti-PD-1 antibody-Resistance Dr. Hiroaki Kinoh, Principal Researcher, Innovation Center of NanoMedicine, Japan |
|
10:50-11:10 |
Title: Finding a Potential Prognostic Biomarker with Analyzing A Serum Soluble CD26/DPP4 Titer Variation from Baseline in Cancer Treatment on Patients with CD26+Tumor in Phase I and Phase I/II Clinical Trials by a Humanized anti-CD26 Monoclonal Antibody Therapy Dr. Yutaro Kaneko, CEO, Y'sAC Co., Ltd., Japan |
|
11:10-11:30 |
Title: Development of New Strategies for the Treatment of Cancer Using Natural Products Dr. Fuad Fares, Professor, Department of Human Biology, Faculty of Natural Sciences, University of Haifa, Israel |
|
WCC 03: Cancer Therapy & Treatments-Part I Time: 08:30-12:10, July 23, 2023 (Sunday); Place: Plaza 3, B1, Catalonia Barcelona Plaza |
|
|
|
|
|
Chair |
Dr. Hariprasad Vankayalapati, Chief Scientific Officer, Biolexis Therapeutics, Inc., USA |
|
Co-Chair |
Dr. Zhirui Wang, Associate Professor, University of Colorado Anschutz Medical Campus, USA |
|
|
|
|
08:30-08:35 |
Chair's Introduction |
|
08:35-08:55 |
Title: Measurement of Small Blood and Lymphatic Vessels in the Brain Using Novel MRI Techniques Dr. Jun Hua, Associate Professor, Johns Hopkins University School of Medicine, USA |
|
08:55-09:15 |
Title: Haemorrhagic Small Bowel Melanoma Metastasis: A Clinical Rarity Dr. Alexandros Zoumpos, Physician, Helios Klinik Herzberg/Osterode, Germany |
|
09:15-09:35 |
Title: Engineering Thermoplasmonic Nanomaterials for Theranostic Applications Dr. Wing-Cheung Law, Associate Professor, The Hong Kong Polytechnic University, Hong Kong, China |
|
09:35-09:55 |
Title: Manufacturing Control of Investigational CAR-T-cell Products: Standards, Guidelines and Opportunities Dr. Devanjan Sikder, Associate Director, Memorial Sloan-Kettering Cancer Center, USA |
|
09:55-10:15 |
Title: CCR4-IL2 Bispecific Immunotoxin for Targeted Therapy of Cutaneous T-Cell Lymphoma Dr. Zhirui Wang, Associate Professor, University of Colorado Anschutz Medical Campus, USA |
|
10:15-10:30 |
Coffee Break |
|
10:30-10:50 |
Title: Labyrinthin Moves from Bench-To-Clinic as Both Neo- and Pan-Adenocarcinoma Target Dr. Michael Babich, Co-Founder and CEO, LabyRx Immuno-Oncology, Sacramento, USA |
|
10:50-11:10 |
Title: AI/ML Driven Discovery and Development of Cancer Immunotherapeutics through Small Molecules and Targeted Protein Degraders Dr. Hariprasad Vankayalapati, Chief Scientific Officer, Biolexis Therapeutics, Inc., USA |
|
11:10-11:30 |
Title: A Novel Genetically Engineered Blood System for Cancer Therapy Dr. James Che-Kun Shen, Chair Professor, Taipei Medical University, Taiwan |
|
11:30-11:50 |
Title: Chemotherapy Response Prediction from Ovarian Cancer Histopathology Images Using Deep Learning Dr. Yuexin Liu, Associate Professor, The University of Texas MD Anderson Cancer Center, USA |
|
11:50-12:10 |
Title: High-Sensitivity Organ-Targeted PET Camera for Cancer Detection and Treatment Follow Up |
|
WCC 04: Clinical Oncology Time: 13:30-17:30, July 23, 2023 (Sunday); Place: Plaza 3, B1, Catalonia Barcelona Plaza |
|
|
|
|
|
Chair |
Dr. Junichi Arita, Professor, Department of Gastroenterological Surgery, Akita University, Japan |
|
Co-Chair |
Dr. Andrew H. Rodgers, Director of Regulatory & Analytical Affairs, Dekk Tec. Inc., USA |
|
|
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-13:55 |
Title: Female Students' Knowledge, Beliefs, Attitude and Practice of Breast Self-Examination in a University in the Western Cape Ms. Mavis Bobie Ansah, Oncology Nurse Specialist, Komfo Anokye Teaching Hospital, Ghana |
|
13:55-14:15 |
Title: Updates in Thyroid Nodules Management Dr. Thanh D. Hoang, Program Director, Walter Reed National Military Medical Center, USA |
|
14:15-14:35 |
Title: Repeat Resection of Neuroendocrine Liver Metastases and Possibility of Cure Dr. Junichi Arita, Professor, Department of Gastroenterological Surgery, Akita University, Japan |
|
14:35-14:55 |
Title: ROS Homeostasis and Metabolism: A Double-Edged Sword in Hepatocellular Carcinoma Dr. Eunyoung Tak, Associate Professor, University of Ulsan, South Korea |
|
14:55-15:15 |
Title: Reconstructive Surgery of the Upper Lip after Combined Resection of the Upper Lip and Buccal Mucosa for Oral Cancer Dr. Kazuhide Matsunaga, Associate Professor, Osaka University, Japan |
|
15:15-15:30 |
Coffee Break |
|
15:30-15:50 |
Title: Up-date: Use of 4-demethyl-4-cholesteryloxycarbonyl-penclomedine (DM-CHOC-PEN) as Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) Involving the CNS Dr. Andrew H. Rodgers, Director of Regulatory & Analytical Affairs, Dekk Tec. Inc., USA |
|
15:50-16:10 |
Title: Rare Cutaneous Tumors: A Case Report of Angiosarcoma and Primary Cutaneous Lymphoma Dr. Typhannie Coelho Borges Silva, Tocantinense University Center Presidente Antônio Carlos - UNITPAC, Brazil |
|
16:10-16:30 |
Title: Advanced Oral Cancers Surgical Management Dr. Harsh Dhar, Consultant Head Neck and Skull Base Surgeon, Medica Superspeciality Hospitals & Cancer Centre, India |
|
16:30-16:50 |
Title: Impact of Viral Burden and Trajectory of Hepatocellular Carcinoma in Armenia Dr. Hasmik Ghazinyan, Nork Clinical Hospital of Infectious Diseases, Armenia |
|
16:50-17:10 |
Title: Hepatic Resections an Liver Transplantation: Signaling Pathways Involved in Protection Against Hepatic Ischemia-Reperfusion Damage and Liver Regeneration Failure: Role of Liver-Adipose Tissue Axis Dr. Carmen Peralta, Senior Group Leader, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Spain |
|
17:10-17:30 |
Title: Phase II trial: Dose-optimized stereotactic Body Radiotherapy for Locally Advanced or Recurrent Pancreatic Adenocarcinoma (ORP-001) Dr. Thomas Gryc, Nordstrahl Nürnberg, Germany |
|
WCC 05: Cancer Therapy & Treatments-Part II Time: 08:30-12:30, July 24, 2023 (Monday); Place: Plaza 3, B1, Catalonia Barcelona Plaza |
|
|
|
|
|
Chair |
Dr. Thomas Boldicke, Senior Scientist, Helmholtz Centre for Infection Research, Germany |
|
Co-Chair |
Dr. Jerome H. Check, Professor, Cooper Medical School of Rowan University, USA |
|
|
|
|
08:30-08:35 |
Chair's Introduction |
|
08:35-08:55 |
Title: Treatment with Progesterone Antagonists May be the Key to Converting Many End-Stage Cancers into a Chronic Disease with Low Morbidity Dr. Jerome H. Check, Professor, Cooper Medical School of Rowan University, USA |
|
08:55-09:15 |
Title: Targeting Microtubule Stabilization to Reduce Breast Cancer Metastasis Dr. Stuart S. Martin, Deputy Director, Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, USA |
|
09:15-09:35 |
Title: Absorbed Dose and Its Determination in Hadrontherapy Dr. Grazia Gambarini, Professor, National Institute of Nuclear Physics (INFN), Section of Milano, Italy |
|
09:35-09:55 |
Title: Therapeutic Inhibitors of Kelly Neuroblastoma Cell Line Progression Dr. Nada Al-Hasawi, Assistant Professor, Collage of Pharmac, Kuwait University, Kuwait |
|
09:55-10:15 |
Title: Triple Negative Breast Cancer Therapy: A Novel Approach Dr. Antonio Ponzetto, Retired Professor of Gastroenterology, University of Torino, Italy |
|
10:15-10:30 |
Coffee Break |
|
10:30-10:50 |
Title: Mature TERATOMA in the Right Ventricle Dr. Fekede D. Agwar, Cardiac Surgeon, Addis Ababa University, Ethiopia |
|
10:50-11:10 |
Title: The Role of SNAIL 1 and SNAIL 2 Transcriptional Factors in the Development of Ovarian Cancer Cells' Chemoresistance in the Context of Their Metastatic Potential Dr. Michal Kielbik, Assistant Professor, Institute of Medical Biology, Polish Academy of Sciences, Poland |
|
11:10-11:30 |
Title: Pigmented Lesion on the Face: Which is the Chance of Being Melanoma Using Reflectance Confocal Microscopy Features Dr. Fernanda Mendes, Physician, AC Camargo Cancer Center, Brazil |
|
11:30-11:50 |
Title: Therapeutic Potential of Intrabodies Against Neoantigens: Current Status and Future Directions Dr. Thomas Boldicke, Senior Scientist, Helmholtz Centre for Infection Research, Germany |
|
11:50-12:10 |
Title: Merkel Cell Carcinoma: Clinical Review and Incorporation of Serologic Testing in Surveillance |
|
12:10-12:30 |
Title: Three Years Experience in Radio-Oncology on Halcyon 2.0 in the Democratic Republic of Congo Dr. Abou Dao, Assistant Teacher, Université Joseph Ki-Zerbo, Democratic Republic of Congo |
|
WCC 06: Oncology Nursing and Prevention Time: 13:30-17:10, July 24, 2023 (Monday); Place: Plaza 3, B1, Catalonia Barcelona Plaza |
|
|
|
|
|
Chair |
Dr. Jacqueline T. Norrell, Director, Rutgers Cancer Institute, USA |
|
|
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-13:55 |
Title: Complexity of Care and Nursing Management of Toxicities in Cancer Patients Receiving Immunotherapy Including Cellular Therapy Treatments: The New Phenotype Dr. Jacqueline T. Norrell, Director, Rutgers Cancer Institute, USA |
|
13:55-14:15 |
Title: Improving Medication Adherence and Symptom Management in Patients with Cancer Dr. Carla Schaefer, Associate Chief Nursing Officer, The State University of New Jersey, USA |
|
14:15-14:35 |
Title: Innovation in Ambulatory Cancer Care-Memorial Sloan Kettering Cancer Center Dr. Geema Shetty Masson, Associate Professor, Memorial Sloan Kettering Cancer Center; Assistant Professor, Weill Cornell Medical School, USA |
|
14:35-14:55 |
Title: Outpatient Palliative Care for Advance Cancer Patients: Implementation of a Day Hospital Dr. Laura Thery, Consultant, Institut Curie, France |
|
14:55-15:15 |
Title: Cognitive Deficits and Psychopathological Symptoms among Children with Medulloblastoma Dr. Annamária Szentes, Clinical Child Psychologist, Semmelweis University, Hungary |
|
15:15-15:30 |
Coffee Break |
|
15:30-15:50 |
Title: Combining the American Thyroid Association's Ultrasound Classification with Cytological Subcategorization Improves the Assessment of Malignancy Risk in Indeterminate Thyroid Nodules Dr. Aline Machado Larcher de Almeida, School of Medicine of Federal University of Rio de Janeiro, Brazil |
|
15:50-16:10 |
Title: Production and Prebiotic Properties of Oligofructans from Sugarcane Juice Fermentation by Bacillus subtilis TISTR 001 Dr. Boontiwa Ninchan, Assistance Professor, Kasetsart University, Thailand |
|
16:10-16:30 |
Title: The Impact of Social Vulnerability on Time to Treatment Disparities Among Insured Adult Patients with Metastatic Cancers Dr. Teresa M. Zyczynsk, Director, Customer Strategy & Solutions, Bristol-Myers Squibb, USA |
|
16:30-16:50 |
Title: Coping Strategies and Their Impact on Emotional Distress and Fatigue among Breast Cancer Survivors Dr. Inbar Levkovich, Associate Professor, Oranim Academic College of Education, Israel |
|
16:50-17:10 |
Title: Epidemiology of Breast Cancer in Women Based on Diagnosis Data from Oncologists and Senologists in Algeria Dr. A Boudjella, Blida 1 University, Algeria |
|
WCC 07: Video Forum |
|
|
WCC 01 |
Title: Predicting Response to Immunotherapy in Head and Neck Cancer Dr. Priyanka Bhateja, Assistant Professor, The Ohio State University, USA |
|
WCC 02 |
Title: Molecular Iodine in Chemoresistant Cancers Dr. Carmen Aceves, Universidad Nacional Autómona de México, México |
|
WCC 03 |
Title: Carcinoma-associated Fibroblasts Derived Exosomes Modulate Breast Cancer Cell Stemness Through Exonic circHIF1A by miR-580-5p in Hypoxic Stress Dr. Yonglei Liu, Zhongshan Hospital Qingpu Branch, Fudan University, China |
|
WCC 04 |
Title: Assessment of Extremely Low Frequency Electromagnetic Field Exposure in Children in Residential Settings through Machine Learning Dr. Gabriella Tognola, Cnr-Istituto di Elettronica e di Ingegneria dell’Informazione e delle Telecomunicazioni (CNR-IEIIT) Milano, Italy |
|
WCC 05 |
Title: Repeat Periods of Electrical Stimulation Prolong the Modulation of the Micturition Reflex in the Rat Dr. Chonghe Jiang, The Sixth Affiliated Hospital of Guangzhou Medical University, China |
|
WCC 06 |
Title: Thyroid Nodule and Risk of Malignancy: an Update Approach Dr. Mohammed Abdulaziz Aldawish, PSMMC, Saudi Arabia |
|
Posters & Papers |
|
|
1 |
Title: Characteristic and Prognostic Differences According to Sentinel Lymph Node Biopsy Implementation During Total Mastectomy in Patients with Ductal Carcinoma in situ Dr. Bong Kyun Kim, Department of Surgery, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea |
|
2 |
Title: Successful Treatment of Smouldering Human T cell Leukemia Virus Type1 Associated Bronchiolitis and Alveolar Abnormalities with Amplified Natural Killer Therapy Dr. Kenjiro Nagai, Vice President, Yokohama City University School of Medicine Graduate School of Medicine, Yokohama, Kanagawa, Japan |
|
3 |
Title: An Extremely Rare Case of Malignant Jejunal Mesenteric Inflammatory Myofibroblastic Tumor in a 61-year-old Male Patient: A Case Report and Literature Review |
Hosting Organization
Official Travel Agency
Media
Partners
Contact Us
Add: Life Science Innovation Center BLD 3-2, 43 Torch Road,
High Tech Park, Dalian, LN 116023, China
© 2003-2023 All rights reserved by BIT Congress
